FatPipe (FATN) Q2 2027 Earnings Call Transcript

FatPipe reported Q2 revenue of $4.83 million, up 22% year over year, and net income of $1.2 million versus a $40,000 loss a year earlier; adjusted EBITDA rose 60% to about $1.2 million, with a 24.1% margin. Recurring billings increased 55% to $2.9 million, and management said the company reached cash-flow break-even in October; it targets at least 18% growth and an 18% EBITDA margin in upcoming quarters. Management said Constellation has begun generating orders, while SATBoost adoption has been slower than hoped; it also refinanced an SBA loan, reducing its interest rate by 1.85%, and secured a $1.5 million bank credit line.

Analysis

FATN’s key underwriting question is whether recurring billings translate into durable, collectible revenue—not whether one quarter’s growth is strong. Flat product RPO despite faster recurring billings may reflect legacy-contract conversion, but it also limits visibility into net-new contracted demand. Reconcile billings, bookings, deferred revenue and RPO in the SEC filing before treating the acceleration as a rerating signal; management’s characterization of revenue as reflective of bookings is not a substitute for those disclosures.

Near term, inventory purchases and deployment timing can make reported cash generation lumpy. The October break-even claim is a single-month management datapoint, while the new credit line and planned sales hiring create competing demands on liquidity. If hires take 3–9 months to contribute, expense growth can precede bookings into the next several quarters. The strongest potential upside is Constellation: device-based pricing and an easier add-on sale could improve customer expansion economics, but early orders do not yet establish material recurring revenue or competitive displacement. SATBoost appears more dependent on customers adopting satellite as primary transport than on redundancy use; Starlink deployments are a catalyst, not proof of demand.

Competitive wins against expiring VeloCloud contracts could support a niche SD-WAN share-gain thesis, but incumbent replacement timing makes conversion lumpy. Any direct read-through to CSCO or FTNT is immaterial absent evidence of meaningful share or financial impact; SNX’s channel relationship is an unquantified pipeline option, not earnings visibility. Contrarian risk: headline profitability and 90% gross margin may overstate operating leverage if growth requires sustained hiring, hardware working capital, and acquisition spending. Thesis improves with sequential RPO growth and sustained operating cash flow; it weakens if billings decelerate or cash use persists.

Key Decisions for Investors

• FATN: Do not chase the call-driven optimism. Consider only a small, staged long after the next filing confirms operating cash flow, recurring-billings quality, and the bridge between bookings, RPO, and deferred revenue. No price target is supportable from the supplied data.
• For the next 1–3 months, track sequential product RPO, cash conversion after inventory purchases, and sales-hire productivity. A flat or falling RPO alongside continued billings growth would challenge the durability thesis; persistent cash consumption would invalidate the October break-even signal.
• Treat Constellation and SATBoost as watch items, not current valuation drivers. Upgrade the former only if management discloses material paid adoption or renewal attach; require evidence of satellite use for primary transport before underwriting SATBoost growth.
• No actionable CSCO, FTNT, or SNX trade: the disclosed competitive anecdotes and reseller pipeline are too small or unquantified to support a reliable earnings read-through.